Anand Srivastava

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Venues

Microbiology spectrum

Antimicrobial agents and chemotherapy

Scientific reports

Cell death discovery

Institut National de la Transfusion Sanguine

Jawaharlal Nehru University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut National de la Transfusion Sanguine Feb 01 2011 - Dec 31 2012

France

Post doctoral researcher

Institut Pasteur Mar 25 2008 - Jan 31 2011

France

Post doctoral researcher :: Biology of Host-Parasite Interactions unit

Education History

Jawaharlal Nehru University Sep 15 2002 - Mar 14 2008

India

PHD

University of Allahabad Oct 31 1999 - Dec 31 2001

India

MSC :: Centre for Biotechnology

University of Delhi Jun 01 1996 - Jun 01 1999

India

BSC

Publications

Prajna Parimita Kar, Prasanna Babu Araveti, Kanika Saxena, Atlanta Borah, Puran Singh Sijwali, Anand Srivastava
Cimicifugin, a broad-spectrum inhibitor of Theileria annulata and Plasmodium falciparum CDK7. Antimicrobial agents and chemotherapy 68 (8) (2024)
Prajna Parimita Kar, Prasanna Babu Araveti, Kanika Saxena, Atlanta Borah, Puran Singh Sijwali, Anand Srivastava
Cimicifugin, a broad-spectrum inhibitor of Theileria annulata and Plasmodium falciparum CDK7. Antimicrobial agents and chemotherapy (2024)
Prajna Parimita Kar, Prasanna Babu Araveti, Kanika Saxena, Atlanta Borah, Puran Singh Sijwali, Anand Srivastava
Cimicifugin, a broad-spectrum inhibitor of Theileria annulata and Plasmodium falciparum CDK7. Antimicrobial agents and chemotherapy 68 (8) (2024)
Prajna Parimita Kar, Prasanna Babu Araveti, Kanika Saxena, Atlanta Borah, Puran Singh Sijwali, Anand Srivastava
Cimicifugin, a broad-spectrum inhibitor of Theileria annulata and Plasmodium falciparum CDK7. Antimicrobial agents and chemotherapy 68 (8) (2024)
Prasanna Babu Araveti, Prajna Parimita Kar, Akshay Kuriakose, Achintya Sanju, Kota Arun Kumar, Anand Srivastava
Identification of a Novel Interaction between Theileria Prohibitin ( Ta PHB-1) and Bovine RuvB-Like AAA ATPase 1. Microbiology spectrum 11 (1) (2023)
Prasanna Babu Araveti, Prajna Parimita Kar, Akshay Kuriakose, Achintya Sanju, Kota Arun Kumar, Anand Srivastava
Identification of a Novel Interaction between Theileria Prohibitin ( Ta PHB-1) and Bovine RuvB-Like AAA ATPase 1. Microbiology spectrum 11 (1) (2023)
Prasanna Babu Araveti, Prajna Parimita Kar, Akshay Kuriakose, Achintya Sanju, Kota Arun Kumar, Anand Srivastava
Identification of a Novel Interaction between Theileria Prohibitin ( Ta PHB-1) and Bovine RuvB-Like AAA ATPase 1. Microbiology spectrum (2023)
Prasanna Babu Araveti, Prajna Parimita Kar, Akshay Kuriakose, Achintya Sanju, Kota Arun Kumar, Anand Srivastava
Identification of a Novel Interaction between Theileria Prohibitin ( Ta PHB-1) and Bovine RuvB-Like AAA ATPase 1. Microbiology spectrum 11 (1) (2023)
Prasanna Babu Araveti, Prajna Parimita Kar, Akshay Kuriakose, Achintya Sanju, Kota Arun Kumar, Anand Srivastava
Identification of a Novel Interaction between Theileria Prohibitin ( Ta PHB-1) and Bovine RuvB-Like AAA ATPase 1. Microbiology spectrum 11 (1) (2023)
Prasanna Babu Araveti, Anand Srivastava
Curcumin induced oxidative stress causes autophagy and apoptosis in bovine leucocytes transformed by Theileria annulata. Cell death discovery 5 (2019)
Stéphane Gangnard, Arnaud Chêne, Sébastien Dechavanne, Anand Srivastava, Marion Avril, Joseph D Smith, Benoît Gamain
VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design. Scientific reports 9 (1) (2019)
Arnaud Chêne, Stéphane Gangnard, Célia Dechavanne, Sebastien Dechavanne, Anand Srivastava, Marilou Tétard, Sophia Hundt, Odile Leroy, Nicolas Havelange, Nicola K Viebig, Benoît Gamain
Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development. NPJ vaccines 3 (2018)

Anand Srivastava

Publication Activity (10 Years)

Top Topics

Top Venues